COCP — Cocrystal Pharma Inc

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Cocrystal Pharma Inc

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$1.20
Market Cap$17.1M
Float9.1M
Shares Outstanding13.8M
Price/Sales (TTM)92.45
vs. Analyst Target+566.7% to analyst PT
Revenue (TTM)$510,000
Dividend RateNone
Analyst Target Price$8.00 (2 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $2.0M -$9.6M -$4.0M -$9.4M
2021 $5.4M -$14.2M -$8.8M -$14.0M
2022 N/A -$38.8M -$12.4M -$18.0M
2023 N/A -$18.0M -$15.2M -$21.0M
2024 N/A -$17.5M -$12.5M -$17.8M
2025 N/A -$8.8M -$376,000 -$8.6M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Mar 2025 N/A -$2.3M
Jun 2025 N/A -$2.1M
Sep 2025 N/A -$2.0M
Dec 2025 N/A -$2.4M

Ownership & Float

Insider Ownership25.4%
Institutional Ownership5.5%
Short Float6.4%
% of All Funds Holding0.35%
Number of Funds Holding27

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$1.28Near-term / short-term trend
Weekly40-Week SMA$1.18Medium-term trend
Weekly80-Week SMA$1.48Cyclical trend (business cycle)
Weekly200-Week SMA$1.98Secular trend (multi-year)
Monthly10-Month SMA$1.16Near-term monthly trend
Monthly20-Month SMA$1.45Medium-term monthly trend
Monthly40-Month SMA$1.72Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$1.10 support 5.80x 0 months ago
$1.70 resistance 3.69x 8 months ago
$2.20 resistance 1.38x 21 months ago

Historical Earnings Reactions (51 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.23% 0.00% 35.29% 4.62% -11.46%
1 Day -1.31% 0.00% 31.37% 10.14% -25.81%
1 Week -2.19% -3.38% 31.37% 47.92% -33.33%
2 Weeks -0.23% -2.50% 33.33% 89.66% -68.57%
1 Month -1.46% -4.54% 36.00% 78.65% -57.73%

Next earnings: May 21, 2026 (4 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan0.4%35.7%14
Feb7.2%28.6%14
Mar-2.5%33.3%15
Apr-5.7%40.0%15
May0.6%50.0%14
Jun6.6%57.1%14
Jul-6.4%28.6%14
Aug-0.7%35.7%14
Sep-9.2%21.4%14
Oct-7.1%28.6%14
Nov21.3%57.1%14
Dec-7.8%21.4%14

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.00% 32.9% 672
Tuesday 0.35% 32.7% 734
Wednesday -0.18% 33.4% 731
Thursday 0.01% 34.8% 719
Friday 0.35% 34.5% 718

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 5.5%

Insider Transactions — Smart Summary

Total insider ownership: 25.4%

Founder-led management: Sam Lee (Co-CEO & President)

12-Month Insider Activity Summary

Total Filings7
Net Value+N/A
Net Shares Change229,000
% of Float2.5%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
FROST PHILLIP MD ET AL +$219,803.7 7 7 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-02-25 FROST PHILLIP MD ET AL +$19,952 Transaction at $1.00, now +20.3%
2026-02-09 FROST PHILLIP MD ET AL +$47,280 Transaction at $0.95, now +26.9%
2026-01-02 FROST PHILLIP MD ET AL +$47,275 Transaction at $0.95, now +26.9%
2025-12-29 FROST PHILLIP MD ET AL +$63,199.5 Transaction at $0.97, now +23.4%
2025-12-31 FROST PHILLIP MD ET AL +$19,310 Transaction at $0.97, now +24.3%
2025-11-28 FROST PHILLIP MD ET AL +$3,975.2 Transaction at $0.99, now +20.7%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Cocrystal Pharma Inc (COCP) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for COCP on Trend Edge →